Prostaglandin E 2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells

Background— Endogenous prostanoids have been suggested to modulate sensitization during experimental allergic asthma, but the specific role of prostaglandin E 2 (PGE 2 ) or of specific E prostanoid (EP) receptors is not known. Objective— Here we tested the role of EP2 signaling in allergic asthma. Methods— Wild type (WT) and EP2−/− mice were subjected to ovalbumin sensitization and acute airway challenge. The PGE 2 analog misoprostol was administered during sensitization in both genotypes. In vitro culture of splenocytes and of flow-sorted dendritic cells and T cells defined the mechanism by which EP2 exerted its protective effect. Adoptive transfer of WT and EP2−/− CD4 T cells was used to validate the importance of EP2 expression on T cells. Results— As compared to WT mice, EP2−/− mice had exaggerated airway inflammation in this model. Splenocytes and lung lymph node cells from sensitized EP2−/− mice produced more IL-13 than did WT cells, suggesting increased sensitization. In WT but not EP2−/− mice, subcutaneous administration of a stable PGE 2 analog during sensitization inhibited allergic inflammation. PGE 2 decreased cytokine production and inhibited STAT6 phosphorylation by CD3/CD28-stimulated CD4 pos T cells. Co-culture of flow cytometry-sorted splenic CD4 pos T cells and CD11c pos dendritic cells from WT or EP2−/− mice suggested that the increased IL-13 production in EP2−/− mice was due to the lack of EP2 specifically on T cells. Adoptive transfer of CD4 pos EP2−/− T cells caused greater cytokine production in the lungs of WT mice than did transfer of WT CD4 pos T cells. Conclusion— We conclude that the PGE 2 -EP2 axis is an important endogenous brake on allergic airway inflammation, primarily targets T cells, and its agonism represents a potential novel therapeutic approach to asthma. study, we sought to specifically interrogate the role of the PGE 2 -EP2 axis in controlling sensitization and polarization in a model Our data support an important suppressive role for PGE in and further identify on as mediating 2 of

[1]  Chunli Feng,et al.  Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation , 2012, Proceedings of the National Academy of Sciences.

[2]  B. Koller,et al.  Prostaglandin E2 Produced by the Lung Augments the Effector Phase of Allergic Inflammation , 2012, The Journal of Immunology.

[3]  B. Sastre,et al.  Role of PGE2 in Asthma and Nonasthmatic Eosinophilic Bronchitis , 2012, Mediators of inflammation.

[4]  D. Aronoff,et al.  Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling. , 2012, Blood.

[5]  M. Fresno,et al.  Prostaglandin E2 and T cells: friends or foes? , 2011, Immunology and cell biology.

[6]  M. Peters-Golden,et al.  Airway remodeling in murine asthma correlates with a defect in PGE2 synthesis by lung fibroblasts. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[7]  A. Amberbir,et al.  Frequent Use of Paracetamol and Risk of Allergic Disease Among Women in an Ethiopian Population , 2011, PloS one.

[8]  C. Coban,et al.  Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. , 2011, Immunity.

[9]  L. Pujols,et al.  Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2 , 2009, Journal of Inflammation.

[10]  V. Backer,et al.  Regular use of non‐steroidal anti‐inflammatory drugs increases the risk of adult‐onset asthma: a population‐based follow‐up study , 2009, The clinical respiratory journal.

[11]  M. Okano,et al.  Prostaglandin E(2) suppresses staphylococcal enterotoxin-induced eosinophilia-associated cellular responses dominantly through an E-prostanoid 2-mediated pathway in nasal polyps. , 2009, The Journal of allergy and clinical immunology.

[12]  J. Roca‐Ferrer,et al.  Subcutaneous Prostaglandin E2 Restrains Airway Mast Cell Activity in vivo and Reduces Lung Eosinophilia and Th2 Cytokine Overproduction in House Dust Mite-Sensitive Mice , 2009, International Archives of Allergy and Immunology.

[13]  M. Peters-Golden,et al.  Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling , 2009, The Journal of experimental medicine.

[14]  G. Sturm,et al.  Prostaglandin E2 Inhibits Eosinophil Trafficking through E-Prostanoid 2 Receptors1 , 2008, The Journal of Immunology.

[15]  A. Nials,et al.  Mouse models of allergic asthma: acute and chronic allergen challenge , 2008, Disease Models & Mechanisms.

[16]  R. Peebles,et al.  Cyclooxygenase Inhibition during Allergic Sensitization Increases STAT6-Independent Primary and Memory Th2 Responses1 , 2008, The Journal of Immunology.

[17]  G. FitzGerald,et al.  Prostaglandin I2-IP Signaling Blocks Allergic Pulmonary Inflammation by Preventing Recruitment of CD4+ Th2 Cells into the Airways in a Mouse Model of Asthma1 , 2007, The Journal of Immunology.

[18]  J. Frelinger,et al.  Francisella tularensis-Infected Macrophages Release Prostaglandin E2 that Blocks T Cell Proliferation and Promotes a Th2-Like Response1 , 2007, The Journal of Immunology.

[19]  M. Nishibori,et al.  E prostanoid 2 (EP2)/EP4‐mediated suppression of antigen‐specific human T‐cell responses by prostaglandin E2 , 2006, Immunology.

[20]  J. Morrow,et al.  Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent. , 2006, Journal of immunology.

[21]  S. Narumiya,et al.  Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3 , 2005, Nature Immunology.

[22]  Hiroshi Tanaka,et al.  Prostaglandin E2 receptor selective agonists E-prostanoid 2 and E-prostanoid 4 may have therapeutic effects on ovalbumin-induced bronchoconstriction. , 2005, Chest.

[23]  H. Allmers Frequent acetaminophen use and allergic diseases: is the association clear? , 2005, The Journal of allergy and clinical immunology.

[24]  K. Yamagata,et al.  Augmentation of allergic inflammation in the airways of cyclooxygenase‐2‐deficient mice , 2005, Respirology.

[25]  D. Aronoff,et al.  Cutting Edge: Macrophage Inhibition by Cyclic AMP (cAMP): Differential Roles of Protein Kinase A and Exchange Protein Directly Activated by cAMP-11 , 2005, The Journal of Immunology.

[26]  J. Morrow,et al.  Cyclooxygenase Inhibition Augments Allergic Inflammation through CD4-Dependent, STAT6-Independent Mechanisms1 , 2005, The Journal of Immunology.

[27]  T. Nakajima,et al.  Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. , 2004, Human molecular genetics.

[28]  D. Aronoff,et al.  Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP12 , 2004, The Journal of Immunology.

[29]  Lauren Cohn,et al.  Asthma: mechanisms of disease persistence and progression. , 2004, Annual review of immunology.

[30]  J. Regan EP2 and EP4 prostanoid receptor signaling. , 2003, Life sciences.

[31]  J. Morrow,et al.  Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. , 2003, The Journal of clinical investigation.

[32]  Lawrence J. Marnett,et al.  Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Morrow,et al.  Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. , 2002, American journal of respiratory and critical care medicine.

[34]  B. Koller,et al.  Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. , 2001, The Journal of clinical investigation.

[35]  J. Harton,et al.  Downregulation of CIITA Function by Protein Kinase A (PKA)-Mediated Phosphorylation: Mechanism of Prostaglandin E, Cyclic AMP, and PKA Inhibition of Class II Major Histocompatibility Complex Expression in Monocytic Lines , 2001, Molecular and Cellular Biology.

[36]  B. Graham,et al.  Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. , 2000, American journal of respiratory and critical care medicine.

[37]  J. Murray,et al.  Prostaglandin E(2) decreases allergen-stimulated release of prostaglandin D(2) in airways of subjects with asthma. , 2000, American journal of respiratory and critical care medicine.

[38]  D. Zeldin,et al.  Allergic lung responses are increased in prostaglandin H synthase-deficient mice. , 1999, The Journal of clinical investigation.

[39]  Mark A. Magnuson,et al.  Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor , 1999, Nature Medicine.

[40]  H. Karahashi,et al.  Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1. , 1998, Biochemical and biophysical research communications.

[41]  Richard A Flavell,et al.  The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells , 1997, Cell.

[42]  J. Thompson,et al.  Inhaled misoprostol blocks guinea pig antigen-induced bronchoconstriction and airway inflammation. , 1996, American journal of respiratory and critical care medicine.

[43]  M. Kaplan,et al.  Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. , 1996, Immunity.

[44]  R. M. Refini,et al.  Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. , 1996, American journal of respiratory and critical care medicine.

[45]  M. Yacoub,et al.  8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. , 1996, American journal of respiratory and critical care medicine.

[46]  L. Mastalerz,et al.  Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. , 1996, American journal of respiratory and critical care medicine.

[47]  C. Parker,et al.  Suppression of IL-4 Production in Murine Lymphocytes by Orally Effective Prostaglandin E(1) Analogs. , 1995, American journal of therapeutics.

[48]  A. Szczeklik Prostaglandin E2 and aspirin-induced asthma , 1995, The Lancet.

[49]  I. Pavord,et al.  Bronchoprotective role for endogenous prostaglandin E2 , 1995, The Lancet.

[50]  P. O'Byrne,et al.  Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects. , 1994, American journal of respiratory and critical care medicine.

[51]  I. Pavord,et al.  Effect of inhaled prostaglandin E2 on allergen-induced asthma. , 1993, The American review of respiratory disease.

[52]  F. Paliogianni,et al.  Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. , 1992, Journal of immunology.

[53]  M. Betz,et al.  Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. , 1991, Journal of immunology.

[54]  T. Gettys,et al.  Activation of the cAMP cascade inhibits an early event involved in murine macrophage Ia expression. , 1990, The Journal of biological chemistry.

[55]  K. Asano,et al.  Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma. , 2008, Allergology international : official journal of the Japanese Society of Allergology.

[56]  P. O'Byrne,et al.  Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. , 1999, American journal of respiratory and critical care medicine.